Business Context and Reporting Period
Company: Simulations Plus, Inc. (SLP)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended May 31, 2026
Business Overview: A global provider of advanced software and consulting services for the biopharma sector, supporting drug discovery, development, clinical trials, and commercialization.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended May 31, 2026 | Nine Months Ended May 31, 2026 |
|---|---|---|
| Total Revenues | $21,886 | $64,598 |
| Gross Profit | $15,127 | $42,161 |
| Gross Margin | 69% | 65% |
| Net Income | $3,575 | $8,786 |
| Diluted EPS | $0.18 | $0.43 |
| Operating Cash Flow (9mo) | $19,355 | |
| Cash & Equivalents (May 31, 2026) | $35,324 | |
| Short-term Investments (May 31, 2026) | $14,666 | |
| Total Liabilities | $13,941 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 7% ($1.5M) for the quarter and 5% ($2.9M) for the nine months compared to the prior year. This was driven by a 20% increase in Services revenue, while Software revenue remained flat (quarter) or declined slightly (nine months).
- Profitability Turnaround: The Company reported Net Income of $3.6M for the quarter and $8.8M for the nine months, a significant improvement from Net Losses of $67.3M and $64.0M in the prior year periods. This reversal is primarily due to the absence of a $77.2M non-cash impairment charge recorded in the prior year.
- Margin Expansion: Gross margin improved to 69% (quarter) and 65% (nine months) from 64% and 59% respectively, driven by reduced software amortization costs following the prior year's impairment and improved operating efficiency in services.
- Expense Management: Operating expenses decreased significantly year-over-year due to the absence of impairment charges and reduced General & Administrative (G&A) costs. However, Research & Development (R&D) expenses increased 180% for the quarter and 89% for the nine months as the Company shifted resources to innovation and AI capabilities.
Guidance, Outlook, and Material Events
- Pending Merger: On June 15, 2026, the Company entered into a definitive Merger Agreement to be acquired by SP Evolution HoldCo II, LLC (an affiliate of Altaris, LLC). The transaction values the Company at approximately $375 million, with shareholders receiving $18.50 per share in cash. The deal is expected to close in Q4 2026, subject to shareholder and regulatory approval.
- Operational Restrictions: Pending the merger, the Company is subject to interim operating covenants restricting share repurchases, dividends, significant capital expenditures, and new acquisitions.
- Strategic Focus: Management continues to invest in an integrated, cloud-enabled modeling ecosystem with AI-driven capabilities. R&D spend as a percentage of revenue increased to 16% (quarter) and 15% (nine months).
- Tax Rate: The effective tax rate increased to 26% (quarter) and 25% (nine months) from 9% in the prior year, attributed to a less favorable jurisdictional mix of earnings and the absence of favorable discrete items from the prior year.
Investor Verification Checklist
- Merger Completion Risk: Verify the status of shareholder approval and regulatory clearances required to close the $18.50/share acquisition.
- Revenue Sustainability: Assess the organic growth drivers in the Services segment versus the flat/declining Software license revenue.
- R&D Capitalization: Review the capitalization of software development costs ($2.4M for nine months) and the associated amortization schedule to understand future margin impacts.
- Cash Position: Confirm the liquidity position ($50M combined cash and short-term investments) is sufficient to fund operations until the merger closes, given the restrictions on capital allocation.
- Customer Concentration: Note that the three largest customers accounted for 15% of total revenue for the nine months ended May 31, 2026.